Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2025年4月8日
	新闻
	Diagnostic significance of the novel biomarker combination for earlystage non-small cell ... - Frontiers Frontiers Keywords: lung cancer, CA-62, tumor markers, CT, pulmonary nodules. Received: 09 Oct 2024; Accepted: 08 Apr 2025. Copyright: © 2025 Tcherkassova ... 标记为不相关
	Taletrectinib Data Published as FDA Weighs Approval for ROS1+ NSCLC Targeted Oncology The FDA is evaluating a new drug application for taletrectinib in patients with ROS1 fusion–positive non–small cell lung cancer. 标记为不相关
	VANGL2 downregulates HINT1 to inhibit the ATM-p53 pathway and promote cisplatin ... Nature Small cell lung cancer (SCLC), which accounts for approximately 13% of all newly diagnosed lung cancers, is considered the most aggressive subtype [2] ... 标记为不相关
	Obesity Linked to Improved Survival Across Cancers Treated With ICIs Renal and Urology News ... cancers, including: Pulmonary/intrathoracic malignancies (HR, 0.77; 95% CI, 0.72-0.83); Non-small cell lung cancer (HR, 0.74; 95% CI, 0.66-0.83) ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈